France – Vaccins – Acquisition de vaccin anti pneumococcique pour les nourrissons et les jeunes enfants
AI summary
This tender concerns the procurement of pneumococcal vaccine for infants and young children by the Guyane territorial collectivity. The buyer seeks to acquire vaccine doses to support immunization programs for the pediatric population.
Pharmaceutical companies, vaccine manufacturers, or authorized medical distributors with experience in pediatric vaccine supply and regulatory compliance should apply.
Suppliers must be authorized vaccine manufacturers or distributors with regulatory approval to supply pneumococcal vaccines in France. Evidence of quality certification, cold chain management capability, and compliance with EU pharmaceutical standards is required.
Frequently asked questions
What is this tender about?
This tender concerns the procurement of pneumococcal vaccine for infants and young children by the Guyane territorial collectivity. The buyer seeks to acquire vaccine doses to support immunization programs for the pediatric population.
What are the requirements for suppliers?
Suppliers must be authorized vaccine manufacturers or distributors with regulatory approval to supply pneumococcal vaccines in France. Evidence of quality certification, cold chain management capability, and compliance with EU pharmaceutical standards is required.
What type of company should bid?
Pharmaceutical companies, vaccine manufacturers, or authorized medical distributors with experience in pediatric vaccine supply and regulatory compliance should apply.
Who is the buyer?
The buyer is COLLECTIVITE TERRITORIALE DE GUYANE.
When does this tender close?
Submissions close on May 5, 2026.
Acquisition de vaccin anti pneumococcique pour les nourrissons et les jeunes enfants
Acquisition de vaccin anti pneumococcique pour les nourrissons et les jeunes enfants
Scoring criteria not specified
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…